mRNA Cancer Vaccine Shows Promise in Treating Aggressive Brain Tumours
A new mRNA cancer vaccine has shown promising results in reprogramming the immune system to attack tumours within 48 hours. The vaccine has been tested in a human clinical trial with positive outcomes, potentially opening new treatment avenues for aggressive brain tumours.